Abstract
Routine blood chemistry profiles normally include measurements of creatine kinase (CK) activity. Therefore, an increasing number of patients with elevated creatine kinase levels are identified. General practitioners, anesthesiologists, surgeons and neurologists might be confronted with such an unexplained non-cardiac hyperCKemia. Although this problem is not uncommon, it has been the subject of only a few studies. We provide a clinical review of the enzyme CK in humans and of 343 case reports of “idiopathic” persistently elevated CK serum levels. At present, altogether nine studies provide retrospective data on patients admitted to neuromuscular centers for a work-up of “idiopathic” hyperCKemia and/or susceptibility to malignant hyperthermia. After complete examination, including a muscle biopsy, a subclinical myopathy could be delineated in up to 50% of the patients.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Afifi AK (1998) Idiopathic hyperCKemia revisited. J Child Neurol 13: 251–252.
Blake DJ, Weir A, Newey SE, Davies KE (2002) Function and genetics of dystrophin and dystrophin-related proteins in muscle. Physiol Rev 82: 291–329.
Brewster LM, de Visser M (1988) Persistent hyperCKemia: fourteen patients studied in retrospect. Acta Neurol. Scand 77: 60–63.
Clarkson PM, Hubal MJ (2002) Exercise-induced muscle damage in humans. Am J Phys Med Rehabil 81: S52–69.
Ebashi S, Toyokura Y, Momoi H, Sugita H (1959) High creatine phosphokinase activity of sera of progressive muscular dystrophy. J. Biochem 46: 103–104.
ECCLS European committee for clinical laboratory standards (1988) Lund: ECCLS central office, document number 3–4
Emery AE (2002) The muscular dystrophies. Lancet 359: 687–695.
Galasso PJ, Litin SC, Obrien JF (1993) The macroenzymes: a clinical review. Mayo Clin Proc 68: 349–354.
Garcia W (1974) Elevated creatine kinase phosphokinase levels associated with large muscle mass. J Am Med Assoc 228: 1395–1396.
Joy JL, Shin JOH (1989) Asymptomatic hyperCKemia: an electrophysiologic and histopathologic study. Muscle Nerve 12: 206–209.
Kleppe B, Reimers CD, Altmann C, Pongratz DE (1995) Befunde bei 100 Patienten mit „ätiologisch ungeklärter” Erhöhung der Serumkreatinkinaseaktivität. Med Klin 90: 623–627.
Merlini L, Carbone I, Capanni C, Sabatelli P, Tortorelli S, Sotgia F, Lisanti MP, Bruno C, Minetti C. (2002) Familial isolated hyperCKaemia associated with a new mutation in the caveolin-3 (CAV-3) gene. J Neurol Neurosurg Psychiatry 73: 65–67.
Nevins MA, Saran M, Bright M, Lyon LJ (1973) Pitfalls in interpreting serum creatine phosphokinase activity. J Am Med Assoc 224: 1382–1387.
Prelle A, Rigoletto C, Moggio M, Sciacco M, Comi GP, Ciscato P, Fagiolari G, Rapuzzi S, Bignotti V, Scarlato G (1996) Asymptomatic familiar hyperCKemia associated with desmin accumulation in skeletal muscle. J Neurol Sci 140: 132–136.
Prelle A, Tancredi L, Sciacco M, Chiveri L, Comi GP, Battistel A, Bazzi P, Boneschi FM, Bagnardi V, Ciscato P, Bordoni A, Fortunato F, Strazzer S, Bresolin N, Scarlato G, Moggio M (2002) Retrospective study of a large population of patients with asymptomatic or minimally sympotomatic raised serum ceratine kinase levels. J Neurol 249: 305–311.
Rando TA (2001) The dystrophin-glycoprotein complex, cellular signaling, and the regulation of cell survival in the muscular dystrophies. Muscle Nerve 24: 1575–1594.
Reijneveld JC, Notermans NC, Linssen WHJP, Wokke JHJ (2000) Benign prognosis in idiopathic hyper-CK-emia. Muscle Nerve 23: 575–579.
Rowland LP, Willner J, Cerri C, DiMauro S, Miranda A (1980) Approaches to the membrane theory of Duchenne muscular dystrophy. In: Angelini C, Danieli GA, Fontanari D (eds.): Muscular Dystrophy — Advances and New Trends. Amsterdam, Excerpta Medica, pp 3–13
Steeghs K, Benders A, Oelemans F, de Haan A, Heerschap A, Ruitenbeek W, Jost C, van Deursen J, Perryman B, Pette D, Bruckwilder M, Koudijs J, Jap P, Veerkamp J, Wieringa B (1997) Altered Ca (2+) responses in muscle with combined mitochondrial and cytosolic creatine kinase deficiencies. Cell 89: 93–103.
Stein W (1988) Laboratory diagnosis of acute myocardial infarction: Darmstadt, Germany: GIT-Verlag
Sunohara N, Takagi A, Nonaka I, Sugita H, Satoyoshi E (1984) Idiopathic hyperCKemia. Neurology 34: 544–547.
Weglinski MR, Wedel DJ, Engel AG (1997) Malignant hyperthermia testing in patients with persisting increased serum creatine kinase levels. Anesth Analg 84: 1038–1041.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer
About this chapter
Cite this chapter
Schoser, B.G.H., Witt, T.N. (2004). Differential Diagnosis of Serum Creatine Kinase Elevation. In: Danek, A. (eds) Neuroacanthocytosis Syndromes. Springer, Dordrecht. https://doi.org/10.1007/1-4020-2898-9_10
Download citation
DOI: https://doi.org/10.1007/1-4020-2898-9_10
Publisher Name: Springer, Dordrecht
Print ISBN: 978-1-4020-2897-7
Online ISBN: 978-1-4020-2898-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)